compounded glp 1 fda GLP-1 medications are trending online, but not everything you hear is true. Your health deserves accurate information—not hype. Learn More: https://healthnothype.org/ #HealthNotHype #GLP1 #PatientSafety #HealthEducation #KnowTheFacts FDA is moving to restrict

For now, don't substitute one form of carnitine for another

Statements Author contributions YJ: Data curation, Formal Analysis, Investigation, Software, Writing original draft

Pair with lifestyle basics

Patients should bring their full medical history and medication list to any consultation so the risk discussion is specific, not generic

Rachel Sorvig, a spokesperson for Zepbound and Mounjaro manufacturer Eli Lilly, said in a statement that users should "talk to their health care provider about dosage and duration needs." Studies have shown that people typically regain a substantial amount of weight within a year of stopping GLP-1 medications, and that many people who quit ultimately go back on the drugs

Maintenance injections are recommended every few months to sustain the desired skin lightening and health benefits